About CytoKi Pharma
CytoKi Pharma is a company based in Værløse (Denmark) founded in 2019 by Rasmus Jorgensen.. CytoKi Pharma has raised $45.02 million across 2 funding rounds from investors including Lundbeck Foundation, Seventure Partners and Ysios Capital. The company has 4 employees as of December 31, 2022. CytoKi Pharma offers products and services including CK-0045. CytoKi Pharma operates in a competitive market with competitors including Aclaris Therapeutics, Sana Biotechnology, Semma Therapeutics, Adocia and Altimmune, among others.
- Headquarter Værløse, Denmark
- Employees 4 as on 31 Dec, 2022
- Founders Rasmus Jorgensen
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cytoki Pharma Aps
-
Annual Revenue
-
Net Profit
$-13.94 M (USD)-231as on Dec 31, 2022
-
EBITDA
$-14.71 M (USD)-192as on Dec 31, 2022
-
Total Equity Funding
$45.02 M (USD)
in 2 rounds
-
Latest Funding Round
$45 M (USD), Series A
May 05, 2021
-
Investors
Lundbeck Foundation
& 3 more
-
Employee Count
4
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CytoKi Pharma
CytoKi Pharma offers a comprehensive portfolio of products and services, including CK-0045. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Long-acting IL-22 analogue for treating metabolic and inflammatory conditions
Unlock access to complete
Unlock access to complete
Funding Insights of CytoKi Pharma
CytoKi Pharma has successfully raised a total of $45.02M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $45 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $45.0M
-
First Round
First Round
(28 Apr 2021)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2021 | Amount | Series A - CytoKi Pharma | Valuation | Lundbeck Foundation | |
| Apr, 2021 | Amount | Seed - CytoKi Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CytoKi Pharma
CytoKi Pharma has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Lundbeck Foundation, Seventure Partners and Ysios Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life science companies are funded through venture capital investments.
|
Founded Year | Domain | Location | |
|
Tech & Life Sciences focused stage agnostic VC firm investing in Europe, Asia & the US
|
Founded Year | Domain | Location | |
|
Ysios Capital is recognized as a leading life sciences investor.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CytoKi Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CytoKi Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cytoki Pharma Comparisons
Competitors of CytoKi Pharma
CytoKi Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aclaris Therapeutics, Sana Biotechnology, Semma Therapeutics, Adocia and Altimmune, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel dermatologic therapies are developed for skin conditions.
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
|
|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases and solid tumors are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for metabolic and orphan diseases are developed by Rezolute.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cytoki Pharma
Frequently Asked Questions about CytoKi Pharma
When was CytoKi Pharma founded?
CytoKi Pharma was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Where is CytoKi Pharma located?
CytoKi Pharma is headquartered in Værløse, Denmark.
Who is the current CEO of CytoKi Pharma?
Rasmus Jorgensen is the current CEO of CytoKi Pharma. They have also founded this company.
Is CytoKi Pharma a funded company?
CytoKi Pharma is a funded company, having raised a total of $45.02M across 2 funding rounds to date. The company's 1st funding round was a Seed of $19.16K, raised on Apr 28, 2021.
How many employees does CytoKi Pharma have?
As of Dec 31, 2022, the latest employee count at CytoKi Pharma is 4.
What does CytoKi Pharma do?
CytoKi Pharma was founded in 2019 and is based in Vaerlose, Denmark. Operations focus on the biotechnology sector, where engineered biologics are developed to address epithelial-based diseases. The lead product employs IL22 to target non-hematopoietic epithelial and stromal cells. Tissue damage is reduced, repair is stimulated, inflammation is controlled, and fibrosis-free recovery is supported through promotion of cell survival, proliferation, and regeneration.
Who are the top competitors of CytoKi Pharma?
CytoKi Pharma's top competitors include Sana Biotechnology, Semma Therapeutics and Adocia.
What products or services does CytoKi Pharma offer?
CytoKi Pharma offers CK-0045.
Who are CytoKi Pharma's investors?
CytoKi Pharma has 4 investors. Key investors include Lundbeck Foundation, Seventure Partners, Ysios Capital, and ND Capital.
What is CytoKi Pharma's valuation?
The valuation of CytoKi Pharma is $5.64M as of Apr 2021.